Compounds > 4-(methylnitrosamino)-1-(3-pyridyl)-1-butan-1-ol
Page last updated: 2024-08-26

4-(methylnitrosamino)-1-(3-pyridyl)-1-butan-1-ol and Drug Withdrawal Symptoms

4-(methylnitrosamino)-1-(3-pyridyl)-1-butan-1-ol has been researched along with Drug Withdrawal Symptoms in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Blount, B; Brown, DC; Giovino, GA; Hendershot, TP; O'Malley, S; Swan, GE1
Carmella, SG; Hatsukami, DK; Hecht, SS; Hertsgaard, LA; Jensen, JA; Kotlyar, M; Lindgren, BR; Murphy, SE; Stepanov, I1

Trials

1 trial(s) available for 4-(methylnitrosamino)-1-(3-pyridyl)-1-butan-1-ol and Drug Withdrawal Symptoms

ArticleYear
Effect of oral snus and medicinal nicotine in smokers on toxicant exposure and withdrawal symptoms: a feasibility study.
    Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology, 2011, Volume: 20, Issue:1

    Topics: Adolescent; Adult; Aged; Carbon Monoxide; Cotinine; Feasibility Studies; Humans; Middle Aged; Nicotine; Nitrosamines; Pyridines; Smoking; Smoking Cessation; Substance Withdrawal Syndrome; Tobacco, Smokeless; Young Adult

2011

Other Studies

1 other study(ies) available for 4-(methylnitrosamino)-1-(3-pyridyl)-1-butan-1-ol and Drug Withdrawal Symptoms

ArticleYear
PhenX: Host: Biobehavioral measures for tobacco regulatory research.
    Tobacco control, 2020, Volume: 29, Issue:Suppl 1

    Topics: Adolescent; Adult; Advisory Committees; Carbon Dioxide; Consensus; Cotinine; Cues; Data Collection; Female; Humans; Male; Nitrosamines; Phenotype; Pregnancy; Research Design; Smokers; Smoking; Software; Substance Withdrawal Syndrome; Tobacco Use

2020